SLGL — Sol Gel Technologies Share Price
- $21.87m
- -$2.05m
- $11.54m
- 33
- 47
- 66
- 47
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.76 | ||
Price to Tang. Book | 0.76 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.9 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -39.31% | ||
Return on Equity | -31.35% | ||
Operating Margin | -104.13% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 8.77 | 31.27 | 3.88 | 1.55 | 11.54 | 7.7 | 10.1 | -12.81% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Directors
- Moshe Arkin CHM (68)
- Alon Seri-Levy CEO (59)
- Gilad Mamlok CFO (52)
- Itzik Yosef VOP (44)
- Nissim Bilman VPR (59)
- Ofra Levy-Hacham VPR (54)
- Karine Neimann VPR (49)
- Dubi Zamir VPR (67)
- Ofer Toledano VRD (55)
- John Vieira OTH (51)
- Itai Arkin DRC (33)
- Hani Lerman DRC (48)
- Shmuel Ben Zvi IND (60)
- Jerrold Gattegno IND (68)
- Ran Gottfried IND (76)
- Yaffa Krindel-Sieradzki IND (66)
- Jonathan Siegel IND (47)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 28th, 1997
- Public Since
- February 1st, 2018
- No. of Shareholders
- 1
- No. of Employees
- 34
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market
- Shares in Issue
- 2,785,762

- Address
- Golda Meir 7, NESS-ZIONA, 7403650
- Web
- http://www.sol-gel.com
- Phone
- +972 89313433
- Auditors
- Kesselman & Kesselman
Upcoming Events for SLGL
Q2 2025 Sol Gel Technologies Ltd Earnings Release
Similar to SLGL
Abeona Therapeutics
NASDAQ Capital Market
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
Aclarion
NASDAQ Capital Market
FAQ
As of Today at 23:20 UTC, shares in Sol Gel Technologies are trading at $7.85. This share price information is delayed by 15 minutes.
Shares in Sol Gel Technologies last closed at $7.85 and the price had moved by +5.37% over the past 365 days. In terms of relative price strength the Sol Gel Technologies share price has underperformed the S&P500 Index by -2.77% over the past year.
The overall consensus recommendation for Sol Gel Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreSol Gel Technologies does not currently pay a dividend.
Sol Gel Technologies does not currently pay a dividend.
Sol Gel Technologies does not currently pay a dividend.
To buy shares in Sol Gel Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $7.85, shares in Sol Gel Technologies had a market capitalisation of $21.87m.
Here are the trading details for Sol Gel Technologies:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SLGL
Based on an overall assessment of its quality, value and momentum Sol Gel Technologies is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Sol Gel Technologies is $600.00. That is 7543.31% above the last closing price of $7.85.
Analysts covering Sol Gel Technologies currently have a consensus Earnings Per Share (EPS) forecast of -$0.40 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sol Gel Technologies. Over the past six months, its share price has outperformed the S&P500 Index by +48.45%.
As of the last closing price of $7.85, shares in Sol Gel Technologies were trading +22.19% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sol Gel Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $7.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Sol Gel Technologies' management team is headed by:
- Moshe Arkin - CHM
- Alon Seri-Levy - CEO
- Gilad Mamlok - CFO
- Itzik Yosef - VOP
- Nissim Bilman - VPR
- Ofra Levy-Hacham - VPR
- Karine Neimann - VPR
- Dubi Zamir - VPR
- Ofer Toledano - VRD
- John Vieira - OTH
- Itai Arkin - DRC
- Hani Lerman - DRC
- Shmuel Ben Zvi - IND
- Jerrold Gattegno - IND
- Ran Gottfried - IND
- Yaffa Krindel-Sieradzki - IND
- Jonathan Siegel - IND